These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10713234)

  • 1. Latanoprost versus timolol gel to prevent ocular hypertension after phacoemulsification and intraocular lens implantation.
    Lai JS; Chua JK; Leung AT; Lam DS
    J Cataract Refract Surg; 2000 Mar; 26(3):386-91. PubMed ID: 10713234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intracameral acetylcholine on latanoprost in preventing ocular hypertension after phacoemulsification and intraocular lens implantation.
    Lai JS; Chua JK; Loo A; Ho SY; Lam DS
    J Cataract Refract Surg; 2001 May; 27(5):700-5. PubMed ID: 11377899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative latanoprost to prevent ocular hypertension after phacoemulsification and intraocular lens implantation.
    Lai JS; Loo A; Tham CC; Ho SY; Lam DS
    J Cataract Refract Surg; 2001 Nov; 27(11):1792-5. PubMed ID: 11709253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraindividual comparison of the effects of a fixed dorzolamide-timolol combination and latanoprost on intraocular pressure after small incision cataract surgery.
    Rainer G; Menapace R; Findl O; Petternel V; Kiss B; Georgopoulos M
    J Cataract Refract Surg; 2001 May; 27(5):706-10. PubMed ID: 11377900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of latanoprost, bimatoprost, and travoprost on intraocular pressure after cataract surgery.
    Arici MK; Erdogan H; Toker I; Vural A; Topalkara A
    J Ocul Pharmacol Ther; 2006 Feb; 22(1):34-40. PubMed ID: 16503773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension.
    Larsson LI
    Ophthalmology; 2001 Aug; 108(8):1439-44. PubMed ID: 11470697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timolol 0.1% gel versus timolol 0.5% eyedrops in the prophylaxis of ocular hypertension after phacoemulsification surgery.
    Cagini C; Di Pasquale G; Lupidi M; Cerquaglia A; Pascale A; Boccolucci A; Fiore T
    Eur J Ophthalmol; 2014; 24(6):857-61. PubMed ID: 24760603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect on diurnal intraocular pressure of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension.
    Larsson LI
    Acta Ophthalmol Scand; 2001 Apr; 79(2):125-8. PubMed ID: 11284748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect on intraocular pressure during 24 hours after repeated administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension.
    Larsson LI
    J Glaucoma; 2001 Apr; 10(2):109-14. PubMed ID: 11316092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latanoprost versus timolol gel-forming solution once daily in primary open-angle glaucoma or ocular hypertension.
    Harasymowycz P; Hutnik CM; Nicolela M; Stewart WC
    Can J Ophthalmol; 2007 Feb; 42(1):75-81. PubMed ID: 17361245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of latanoprost on intraocular pressure following cataract extraction.
    Scherer WJ; Mielke DL; Tidwell PE; Hauber FA
    J Cataract Refract Surg; 1998 Jul; 24(7):964-7. PubMed ID: 9682119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timolol gel versus acetazolamide in the prophylaxis of ocular hypertension after phacoemulsification.
    Kanellopoulos AJ; Perry HD; Donnenfeld ED
    J Cataract Refract Surg; 1997 Sep; 23(7):1070-4. PubMed ID: 9379379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antiglaucoma agents on postoperative intraocular pressure after cataract surgery with Viscoat.
    Borazan M; Karalezli A; Akman A; Akova YA
    J Cataract Refract Surg; 2007 Nov; 33(11):1941-5. PubMed ID: 17964402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
    Walters TR; DuBiner HB; Carpenter SP; Khan B; VanDenburgh AM;
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular pressure rise after primary posterior continuous curvilinear capsulorhexis with a fixed dorzolamide-timolol combination: randomized safety study with intraindividual comparison using an angulated and a nonangulated intraocular lens.
    Wirtitsch MG; Menapace R; Georgopoulos M; Rainer G; Buehl W; Heinzl H
    J Cataract Refract Surg; 2007 Oct; 33(10):1754-9. PubMed ID: 17889772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost.
    Stewart WC; Day DG; Sharpe ED; Dubiner HB; Holmes KT; Stewart JA
    Am J Ophthalmol; 1999 Dec; 128(6):692-6. PubMed ID: 10612504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study.
    Aung T; Wong HT; Yip CC; Leong JY; Chan YH; Chew PT
    Ophthalmology; 2000 Jun; 107(6):1178-83. PubMed ID: 10857840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.
    Higginbotham EJ; Olander KW; Kim EE; Grunden JW; Kwok KK; Tressler CS;
    Arch Ophthalmol; 2010 Feb; 128(2):165-72. PubMed ID: 20142538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
    Hatanaka M; Reis A; Sano ME; Susanna R
    J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.
    Olander K; Zimmerman TJ; Downes N; Schoenfelder J;
    Clin Ther; 2004 Oct; 26(10):1619-29. PubMed ID: 15598478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.